Latest in Fda

Image credit:

Satiety's transoral TOGa stomach stapling procedure

Darren Murph

Satiety, Inc. has finally found the funding it needs to push forward with a radical new approach to assisting the obese, as it has rounded up $30 million in financing from a number of venture capitalists who dug the idea. Essentially, the TOGa procedure is a "completely transoral process designed to achieve similar weight loss to restrictive surgeries," and it also claims to be less invasive, require less recovery time, and should create a "dramatically reduced amount of complications." In this system, the physician would "introduce a stapling device transorally and create a restrictive pouch at the entry of the stomach," and moreover, it's considered "non-surgical" in nature, endoscopic, and can be performed by properly trained bariatric surgeons, general endoscopic surgeons, and gastroenterologists. Currently, the firm is moving forward with plans to get the procedure approved by the FDA, and while there's no telling how long such a convoluted process will take, stomach stapling could see an entirely different approach in the years to come if this proves effective.

[Via CNET]

From around the web

ear iconeye icontext filevr